The pharmacokinetics, pharmacodynamics, safety and tolerability of NN2211, a new long-acting GLP-1 derivative, in healthy men
Crossref DOI link: https://doi.org/10.1007/s00125-001-0719-z
Published Online: 2014-05-03
Published Print: 2002-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Agersø, H.
Jensen, L. B.
Elbrønd, B.
Rolan, P.
Zdravkovic, M.
Text and Data Mining valid from 2002-02-01